These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21360626)

  • 1. Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter.
    Chuang YS; Huang WH; Park SW; Persaud SD; Hung CH; Ho PC; Wei LN
    Stem Cells; 2011 Apr; 29(4):660-9. PubMed ID: 21360626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140.
    Wu CY; Feng X; Wei LN
    Nucleic Acids Res; 2014 Apr; 42(7):4306-17. PubMed ID: 24489122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.
    Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH
    Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene.
    Park SW; Huq MD; Loh HH; Wei LN
    J Neurosci; 2005 Mar; 25(13):3350-7. PubMed ID: 15800190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression.
    Gupta P; Ho PC; Huq MM; Ha SG; Park SW; Khan AA; Tsai NP; Wei LN
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11424-9. PubMed ID: 18682553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IUGR increases chromatin-remodeling factor Brg1 expression and binding to GR exon 1.7 promoter in newborn male rat hippocampus.
    Ke X; McKnight RA; Gracey Maniar LE; Sun Y; Callaway CW; Majnik A; Lane RH; Cohen SS
    Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R119-27. PubMed ID: 25972460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Sp1 functions by its sequestration into PML nuclear bodies.
    Li J; Zou WX; Chang KS
    PLoS One; 2014; 9(4):e94450. PubMed ID: 24728382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A; Buchholz DR; Obata K; Shi YB
    J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.
    Vallian S; Chin KV; Chang KS
    Mol Cell Biol; 1998 Dec; 18(12):7147-56. PubMed ID: 9819401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
    Zhu G
    Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic response to environmental stress: Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts.
    Han P; Li W; Yang J; Shang C; Lin CH; Cheng W; Hang CT; Cheng HL; Chen CH; Wong J; Xiong Y; Zhao M; Drakos SG; Ghetti A; Li DY; Bernstein D; Chen HS; Quertermous T; Chang CP
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1772-81. PubMed ID: 26952936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
    Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
    J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells.
    Park SW; Hu X; Gupta P; Lin YP; Ha SG; Wei LN
    Nat Struct Mol Biol; 2007 Jan; 14(1):68-75. PubMed ID: 17187077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of PML/RARalpha impairs myelopoiesis.
    Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIP140 in thyroid hormone-repression and chromatin remodeling of Crabp1 gene during adipocyte differentiation.
    Park SW; Huang WH; Persaud SD; Wei LN
    Nucleic Acids Res; 2009 Nov; 37(21):7085-94. PubMed ID: 19778926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter.
    Witcher M; Pettersson F; Dupéré-Richer D; Padovani A; Summers-Deluca L; Baldwin AS; Miller WH
    Nucleic Acids Res; 2008 Feb; 36(2):435-43. PubMed ID: 18039708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties.
    Segalla S; Rinaldi L; Kilstrup-Nielsen C; Badaracco G; Minucci S; Pelicci PG; Landsberger N
    Mol Cell Biol; 2003 Dec; 23(23):8795-808. PubMed ID: 14612419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes.
    Cho S; Park JS; Kang YK
    J Biol Chem; 2011 Nov; 286(47):41115-24. PubMed ID: 21921037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.